Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA 19104, USA.
Clin Transplant. 2013 Mar-Apr;27(2):185-92. doi: 10.1111/ctr.12052. Epub 2012 Dec 27.
Cardiac arrest associated with reperfusion of the liver allograft in a euvolemic patient is a rare but potentially devastating event. There are few case series describing experience with this complication and no published management protocols guiding treatment. This article is a retrospective case series of patients experiencing post-reperfusion intraoperative cardiac arrest between 1997 and 2011. Among 1581 liver transplants, 16 (1%) patients experienced post-reperfusion cardiac arrest. Among patients with intraoperative arrests, 14 (88%) patients required open cardiac massage. Seven (44%) were placed on cardiopulmonary bypass (CPB) when cardiac activity failed to adequately recover. Placement on CPB reversed cardiac pump failure and established a perfusing rhythm in six of seven (86%) recipients, leading to one of seven (14%) intraoperative mortality. Recovery of myocardial function was associated with low early survival with only 3/7 (43%) patients who underwent CPB surviving until discharge. Among all patients who survived the perioperative period, one-yr survival was 70% (N = 7), and five-yr survival was 50% (N = 5). Cardiac arrest during liver transplantation is associated with a poor prognosis during the perioperative period. In patients who do not recover cardiac activity after standard resuscitative measures, progression to physiologic support with systemic anticoagulation and CPB may allow correction of electrolyte derangements, maintenance of cerebral perfusion, and myocardial recovery.
心脏骤停与肝脏移植再灌注相关,在血容量正常的患者中是一种罕见但潜在的破坏性事件。只有少数病例系列描述了这种并发症的经验,也没有发表的管理方案来指导治疗。本文是对 1997 年至 2011 年期间发生的术后再灌注术中心脏骤停患者的回顾性病例系列研究。在 1581 例肝移植中,16 例(1%)患者发生术后再灌注性心脏骤停。在发生术中骤停的患者中,14 例(88%)患者需要开胸心脏按摩。7 例(44%)患者在心脏活动未能充分恢复时放置心肺旁路(CPB)。CPB 的放置逆转了心脏泵衰竭,并使 7 例(86%)受者中的 6 例建立了灌注节律,导致 7 例(14%)术中死亡。心肌功能的恢复与早期存活率低相关,仅 7 例(43%)接受 CPB 的患者存活至出院。在所有存活至围手术期的患者中,1 年生存率为 70%(N=7),5 年生存率为 50%(N=5)。肝脏移植期间发生的心脏骤停与围手术期预后不良相关。对于标准复苏措施后心脏活动未能恢复的患者,进展到全身抗凝和 CPB 的生理支持可能允许纠正电解质紊乱、维持脑灌注和心肌恢复。